Johnson & Johnson reports Q3 2026 results
- Q3 sales grew 5.9% to $25.4B
- Adjusted EPS was $2.59
- Raised 2026 sales guidance to $101.2B
JNJ
JOHNSON & JOHNSON SEC filings
Every EDGAR filing for JOHNSON & JOHNSON (JNJ), newest first, with AI summaries and stories.
- Ticker
- JNJ
- CIK
- 200406
- Sector
- Biotech and pharma
- Latest filing
- 6d
Next: 10-Q expected ~Oct 22 (deadline Nov 6)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KJOHNSON & JOHNSONJNJLIVE ROUTINE4JOHNSON & JOHNSONJNJLIVE 3 insider filings
Daniel E Pinto, insider filing for JNJ
Show all 3
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
Daniel E Pinto, reporting
ROUTINE4JOHNSON & JOHNSONJNJLIVE Timothy Schmid, insider filing for JNJ
Timothy Schmid, reporting
ROUTINE144JOHNSON & JOHNSONJNJLIVE Timothy Schmid, planned sale of JNJ shares
Timothy Schmid, reporting
ROUTINE3JOHNSON & JOHNSONJNJLIVE Thomas Cavanaugh, new insider at JNJ
Thomas Cavanaugh, reporting
ROUTINE4JOHNSON & JOHNSONJNJLIVE Jennifer L Taubert, insider filing for JNJ
Jennifer L Taubert, reporting
ROUTINE144JOHNSON & JOHNSONJNJLIVE Jennifer L Taubert, planned sale of JNJ shares
Jennifer L Taubert, reporting
ROUTINE4JOHNSON & JOHNSONJNJLIVE Joaquin Duato, insider filing for JNJ
Joaquin Duato, reporting
ROUTINE144JOHNSON & JOHNSONJNJLIVE Joaquin Duato, planned sale of JNJ shares
Joaquin Duato, reporting
ROUTINE4JOHNSON & JOHNSONJNJLIVE 2 insider filings
Joaquin Duato, insider filing for JNJ
Show all 2
- 4Insider filing for JNJ
- 4Insider filing for JNJ
Joaquin Duato, reporting
ROUTINE144JOHNSON & JOHNSONJNJLIVE Elizabeth Forminard, planned sale of JNJ shares
Elizabeth Forminard, reporting
ROUTINE13F-HRJOHNSON & JOHNSONJNJLIVE ROUTINE144JOHNSON & JOHNSONJNJLIVE Joaquin Duato, planned sale of JNJ shares
Joaquin Duato, reporting
ROUTINE8-KJOHNSON & JOHNSONJNJLIVE ROUTINE8-KJOHNSON & JOHNSONJNJLIVE NOTABLE10-QJOHNSON & JOHNSONJNJLIVE ROUTINE4JOHNSON & JOHNSONJNJLIVE Vanessa Broadhurst, insider filing for JNJ
Vanessa Broadhurst, reporting
ROUTINE144JOHNSON & JOHNSONJNJLIVE Vanessa Broadhurst, planned sale of JNJ shares
Vanessa Broadhurst, reporting
ROUTINE8-KJOHNSON & JOHNSONJNJLIVE ROUTINE11-KJOHNSON & JOHNSONJNJLIVE ROUTINE11-KJOHNSON & JOHNSONJNJLIVE ROUTINE4JOHNSON & JOHNSONJNJLIVE Kathryn E Wengel, insider filing for JNJ
Kathryn E Wengel, reporting
ROUTINE4JOHNSON & JOHNSONJNJLIVE 3 insider filings
Eugene A. Woods, insider filing for JNJ
Show all 3
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
Eugene A. Woods, reporting
ROUTINE144JOHNSON & JOHNSONJNJLIVE Kathryn E Wengel, planned sale of JNJ shares
Kathryn E Wengel, reporting
ROUTINESDJOHNSON & JOHNSONJNJLIVE ROUTINE13F-HRJOHNSON & JOHNSONJNJLIVE ROUTINE4JOHNSON & JOHNSONJNJLIVE John C Reed, insider filing for JNJ
John C Reed, reporting
ROUTINESCHEDULE 13GJOHNSON & JOHNSONJNJLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
ROUTINE4JOHNSON & JOHNSONJNJLIVE 11 insider filings
Eugene A. Woods, insider filing for JNJ
Show all 11
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
- 4Insider filing for JNJ
Eugene A. Woods, reporting
NOTABLE10-QJOHNSON & JOHNSONJNJLIVE ROUTINE8-KJOHNSON & JOHNSONJNJLIVE ROUTINESCHEDULE 13G/ARallybio CorpRLYBLIVE Ownership stake disclosure by JOHNSON & JOHNSON (amended)
& Johnson Johnson, filed by
ROUTINESCHEDULE 13G/AJOHNSON & JOHNSONJNJLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
ROUTINE13F-HR/AJOHNSON & JOHNSONJNJLIVE ROUTINE13F-HR/AJOHNSON & JOHNSONJNJLIVE